Granzyme B-responsive fluorescent probe for non-invasive early diagnosis of transplant rejection
Biosensors and Bioelectronics · 2023
DOI: 10.1016/j.bios.2023.115303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2023. Verfasst von Tang Gao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Hubei…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Biosensing Techniques. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Allograft rejection has always been a major obstacle in organ transplantation. The current clinical diagnostic gold standard for allograft rejection is an invasive biopsy. However, biopsy has some limitations, such as sampling errors, risk of serious complications, and high cost. In this study, we have rationally developed an activatable fluorescent probe CYGB for imaging of granzyme B, which is a biomarker released by CD8+T cells attacking the graft. Moreover, the ability of CYGB to detect rejection early in mouse heart and skin transplantation models was evaluated. The probe CYGB consists of a caged hemicyanine-based fluorophore and a GzmB-specifically cleaved peptide substrate linked via a self-immolating spacer, p-aminobenzyl alcohol. Endogenous GzmB in CD8+ T cells specifically activated the near-infrared fluorescence (NIRF) signal of CYGB. In vivo imaging in mice skin and heart graft models, showed that CYGB preferentially accumulates in grafts, enabling early diagnosis of rejection. Moreover, CYGB enables non-invasive assessment of the level of immunosuppression in allogeneic mice treated with FK506. This study provides an alternative method for monitoring the status of allografts without biopsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Hubei Province Clinical Research Center for Medical Imaging, Wuhan, 430022,…
- College of Pharmacy, Chongqing Medical University, Chongqing, 400016, China; Computational Biomedicine (IAS-5/INM-9), Forschungszentrum Jülich, Jülich, 52425, Germany.
Förderung
- Natural Science Foundation of Hubei Province
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Gao, T., Yi, L., Wang, Y., Wang, W., Zhao, Q., Song, Y., Ding, M., Deng, C., Chen, Y., Xie, Y., Wu, W., Jin, Q., Zhang, L., & Xie, M. (2023). Granzyme B-responsive fluorescent probe for non-invasive early diagnosis of transplant rejection. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2023.115303
Vancouver
Gao T, Yi L, Wang Y, Wang W, Zhao Q, Song Y, et al. Granzyme B-responsive fluorescent probe for non-invasive early diagnosis of transplant rejection. Biosensors and Bioelectronics. 2023. doi:10.1016/j.bios.2023.115303
BibTeX
@article{Gao2023,
author = {Gao, Tang and Yi, Luyang and Wang, Yihui and Wang, Wenyuan and Zhao, Qianqian and Song, Yuan and Ding, Mengdan and Deng, Cheng and Chen, Yihan and Xie, Yuji and Wu, Wenqian and Jin, Qiaofeng and Zhang, Li and Xie, Mingxing},
title = {Granzyme B-responsive fluorescent probe for non-invasive early diagnosis of transplant rejection},
journal = {Biosensors and Bioelectronics},
year = {2023},
doi = {10.1016/j.bios.2023.115303}
}
EUVIMED